Allogeneic Hematopoietic Stem-Cell Transplantation Improves Disease-Free Survival Compared to Pediatric-Inspired Berlin-Frankfurt-Munster Chemotherapy in Adult Acute Lymphoblastic Leukemia
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, sa.3, ss.147-153, 2021 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 21 Sayı: 3
- Basım Tarihi: 2021
- Doi Numarası: 10.1016/j.clml.2020.12.014
- Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
- Sayfa Sayıları: ss.147-153
- Anahtar Kelimeler: Acute lymphoblastic leukemia, Allogeneic hematopoietic stem cell transplantation, Berlin-Frankfurt-Munster chemotherapy, Disease free survival, Pediatric-inspired, PEGYLATED-ASPARAGINASE, THERAPY, TRIAL
- Ondokuz Mayıs Üniversitesi Adresli: Evet
Özet
We retrospectively compared 47 acute lymphoblastic leukemia (ALL) patients who received Berlin-Frankfurt-Munster chemotherapy and 83 ALL. patients who underwent allogeneic hematopoietic stem-cell transplantation (AHSCT). While there was no difference in overall survival between the 2 groups, disease-free survival was found to be significantly higher in the AHSCT group.